Skip to main content
Clinical Trials/NCT03625908
NCT03625908
Completed
Not Applicable

Optical CoherenCe Tomography-gUided Coronary Intervention in Patients With Complex lesIons: a Randomized Controlled Trial (OCCUPI Trial)

Yonsei University1 site in 1 country1,604 target enrollmentJanuary 9, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Yonsei University
Enrollment
1604
Locations
1
Primary Endpoint
Composite of major adverse cardiac events (MACEs)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

There is no definite conclusive work about the benefit of OCT-guided PCI, which should be determined in complex PCI, assuming better stent optimization by OCT. In the study, we will explore the clinical implication of OCT-guided PCI of complex lesions.

Detailed Description

Eligible patients will be randomly assigned to either OCT-guided PCI arm and angiography-guided PCI with routine high pressure NC ballooning arm in 1:1 ratio. Within OCT-guided PCI arm, the use of OCT will be also assigned to full OCT-guidance arm and postprocedural OCT only arm. and comparison of stent implantation with and without preprocedural OCT will be evaluated by postprocedural OCT (OCT-defined stent optimization will be assessed). In angiography-guided PCI arm, PCI for complex lesion will be performed without guidance of intravascular imaging, and routine use of high pressure postdilation with NC balloon will be also recommended. Primary endpoint will be evaluated during 12 months after PCI.

Registry
clinicaltrials.gov
Start Date
January 9, 2019
End Date
October 12, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Composite of major adverse cardiac events (MACEs)

Time Frame: 1 year

Composite of major adverse cardiac events (MACEs) - for comparison between OCT-guided PCI vs. angiography-guided PCI

Secondary Outcomes

  • Stroke(1 year (except periprocedural MI - within 48 hours))
  • Stent optimization confirmed by OCT(1 year (except periprocedural MI - within 48 hours))
  • Periprocedural myocardial infarction(1 year (except periprocedural MI - within 48 hours))
  • Each component of MACE(1 year (except periprocedural MI - within 48 hours))
  • Any revascularization(1 year (except periprocedural MI - within 48 hours))
  • Target lesion revascularization(1 year (except periprocedural MI - within 48 hours))
  • Bleeding(1 year (except periprocedural MI - within 48 hours))
  • Contrast-induced Nephropathy(1 year (except periprocedural MI - within 48 hours))

Study Sites (1)

Loading locations...

Similar Trials